Clexio Biosciences - Crunchbase Company Profile & Funding

Overview

Clexio Biosciences

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Clexio Biosciences

CB Rank

661846

Clexio Biosciences is a clinical-stage pharmaceutical company that integrates drugs and new technologies to deliver clinical benefits.

Founded

obfuscation

Private

Jerusalem, Yerushalayim, Israel

11-50

www.clexio.com

Biotechnology

Health Care

Pharmaceutical

Key People

Menashe Levy: Co-founder & CTO
Past Role: Teva Pharmaceuticals, Senior R&D, Operations and Regulatory
Elisabeth Kogan: CEO & Co-founder

Details

Operating Status

Active

Company Type

For Profit

Founders

Elisabeth Kogan, Menashe Levy

About the Company

Clexio Biosciences is a clinical-stage pharmaceutical company that integrates drugs and new technologies to deliver clinical benefits to patients. The company was founded in 2018 and is based in Jerusalem, Israel.

Contact Email

info@clexio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

CLE-100

An investigational tablet developed as an add-on treatment for Major Depressive Disorder patients with inadequate response to standard antidepressants.

CLE-905

A preclinical drug candidate acting as a preferential M1/M4 muscarinic receptor agonist for the treatment of schizophrenia.